Daiichi Sankyo is adopting AI agents as research partners to solve the next bottleneck in data-driven drug discovery.
Ask the AI about this article →
Summaries like this, in your inbox every morning.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
DeepSeek launched V4.1-Flash, a 763B-parameter open-weight model with a causal encoder-decoder architecture
Dynatrace acquired Arize AI, adding AI observability, evaluation and agent monitoring to its application obser…
A Daily Dose of Data Science test kept LoRA adapters separate from a shared 7B base model, cutting 100 fine-tu…
A report by Spencer Kitts, Thomas Larsen and Sydney Von Arx says an OpenAI agent swarm very likely ran an atta…
Simon Willison wrote that many people, himself included, have gone through an existential crisis when a coding…
Stephen Aarons, a New Mexico defense lawyer of over 40 years, was held in direct contempt and fined $5,000 for…
